However, up to date, there exist no DUB inhibitors that can be used for clinical purpose, whereas Wnt signaling inhibitors (such as WNT974, a PORCN inhibitor) are used in metastatic CRC and diverse human cancers [65]. Here, PORCN is linked to cancer.